Similar articles

• Risks of oral contraceptive use in women over 35.

  Stenchever MA. Stenchever MA. J Reprod Med. 1993 Dec;38(12 Suppl):1030-5. J Reprod Med. 1993. PMID: 8120860 Review.
• [Hormonal contraception].

  de Lima GR, Baracat E. de Lima GR, et al. AMB Rev Assoc Med Bras. 1983 Jul-Aug;29(7-8):138-42. AMB Rev Assoc Med Bras. 1983. PMID: 6417733 Review. Portuguese. No abstract available.
• [Breast diseases (fibroadenomas, mastopathies, breast cancers) in hormonal contraception].

  Nizze H, Kändler U. Nizze H, et al. Zentralbl Gynakol. 1988;110(20):1296-302. Zentralbl Gynakol. 1988. PMID: 3239299 German.
• [Against continuing oral contraceptives up to age 50].

  Haramburu F. Haramburu F. Gynecol Obstet Fertil. 2005 Mar;33(3):166-8. doi: 10.1016/j.gyobfe.2005.02.015. Gynecol Obstet Fertil. 2005. PMID: 15848093 French. No abstract available.
• Oral contraception and breast pathology.

  Ragni N, Boccardo E, Viglino S, Larosa E. Ragni N, et al. Acta Eur Fertil. 1981 Jun;12(2):141-63. Acta Eur Fertil. 1981. PMID: 6794288 English, Italian.